These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27012825)

  • 21. Specific up-regulation of p21 by a small active RNA sequence suppresses human colorectal cancer growth.
    Wang LL; Guo HH; Zhan Y; Feng CL; Huang S; Han YX; Zheng WS; Jiang JD
    Oncotarget; 2017 Apr; 8(15):25055-25065. PubMed ID: 28445988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.
    Mao Q; Li Y; Zheng X; Yang K; Shen H; Qin J; Bai Y; Kong D; Jia X; Xie L
    Biochem Biophys Res Commun; 2008 Oct; 375(4):566-70. PubMed ID: 18725195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
    Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
    Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
    Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells.
    Kim CJ; Yoshioka N; Tambe Y; Kushima R; Okada Y; Inoue H
    Int J Cancer; 2005 Oct; 117(1):51-8. PubMed ID: 15880581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
    Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
    Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
    Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
    Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing E-cadherin expression via promoter-targeted miR-373 suppresses bladder cancer cells growth and metastasis.
    Zhang Q; Wang C; Miao S; Li C; Chen Z; Li F
    Oncotarget; 2017 Nov; 8(55):93969-93983. PubMed ID: 29212202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
    Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
    Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Wang X; Chen E; Yang X; Wang Y; Quan Z; Wu X; Luo C
    Oncol Rep; 2016 Mar; 35(3):1375-84. PubMed ID: 26677113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells.
    Chiu SC; Chiu TL; Huang SY; Chang SF; Chen SP; Pang CY; Hsieh TF
    BMC Complement Altern Med; 2017 Dec; 17(1):523. PubMed ID: 29207978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.
    Li J; Li Y; Meng F; Fu L; Kong C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 30042171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
    Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
    Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
    Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.